Childhood cancer, anthracyclines, and the heart
- 1 June 1992
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 339 (8806) , 1388-1389
- https://doi.org/10.1016/0140-6736(92)91203-k
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Long term survival after heart transplantation for doxorubicin induced cardiomyopathy.Archives of Disease in Childhood, 1992
- Cardiac toxicity 4 to 20 years after completing anthracycline therapyPublished by American Medical Association (AMA) ,1991
- Long term survival after heart transplantation for doxorubicin induced cardiomyopathy.Archives of Disease in Childhood, 1991
- Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in ChildhoodNew England Journal of Medicine, 1991
- Reduced cardiotoxicity of doxorubicin by a 6-hour infusion regimen. A prospective randomized evaluationCancer, 1990
- Doxorubicin-Dauerinfusionen - Eine Pilotstudie bei jugendlichen PatientenKlinische Padiatrie, 1988
- Anthracycline analogs The past, present, and futureCancer Chemotherapy and Pharmacology, 1986
- Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous InfusionAnnals of Internal Medicine, 1982
- Daunomycin-induced cardiotoxicity in children and adults: A review of 110 casesPublished by Elsevier ,1977
- AdriamycinAnnals of Internal Medicine, 1974